187 related articles for article (PubMed ID: 30381326)
1. Inhibition of Advanced Glycation End Products Formation Attenuates Cardiac Electrical and Mechanical Remodeling and Vulnerability to Tachyarrhythmias in Diabetic Rats.
Chang GJ; Yeh YH; Chen WJ; Ko YS; Pang JS; Lee HY
J Pharmacol Exp Ther; 2019 Jan; 368(1):66-78. PubMed ID: 30381326
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of advanced glycation endproduct (AGE) rescues against streptozotocin-induced diabetic cardiomyopathy: Role of autophagy and ER stress.
Pei Z; Deng Q; Babcock SA; He EY; Ren J; Zhang Y
Toxicol Lett; 2018 Mar; 284():10-20. PubMed ID: 29174818
[TBL] [Abstract][Full Text] [Related]
3. Diabetes increases formation of advanced glycation end products on Sarco(endo)plasmic reticulum Ca2+-ATPase.
Bidasee KR; Zhang Y; Shao CH; Wang M; Patel KP; Dincer UD; Besch HR
Diabetes; 2004 Feb; 53(2):463-73. PubMed ID: 14747299
[TBL] [Abstract][Full Text] [Related]
4. Aminoguanidine inhibits albuminuria, but not the formation of advanced glycation end-products in skin collagen of diabetic rats.
Degenhardt TP; Fu MX; Voss E; Reiff K; Neidlein R; Strein K; Thorpe SR; Baynes JW; Reiter R
Diabetes Res Clin Pract; 1999 Feb; 43(2):81-9. PubMed ID: 10221660
[TBL] [Abstract][Full Text] [Related]
5. Glycolaldehyde-Derived High-Molecular-Weight Advanced Glycation End-Products Induce Cardiac Dysfunction through Structural and Functional Remodeling of Cardiomyocytes.
Deluyker D; Evens L; Haesen S; Driesen RB; Kuster D; Verboven M; Beliën H; van der Velden J; Lambrichts I; Bito V
Cell Physiol Biochem; 2020 Aug; 54(5):809-824. PubMed ID: 32857934
[TBL] [Abstract][Full Text] [Related]
6. Effect of age receptor blocker and/or anti-inflammatory coadministration in relation to glycation, oxidative stress and cytokine production in stz diabetic rats.
El-seweidy MM; El-Swefy SE; Ameen RS; Hashem RM
Pharmacol Res; 2002 May; 45(5):391-8. PubMed ID: 12123627
[TBL] [Abstract][Full Text] [Related]
7. Cardioprotective effect of propranolol on diabetes-induced altered intracellular Ca2+ signaling in rat.
Tuncay E; Zeydanli EN; Turan B
J Bioenerg Biomembr; 2011 Dec; 43(6):747-56. PubMed ID: 22127436
[TBL] [Abstract][Full Text] [Related]
8. Candesartan Cilexetil Attenuates Arrhythmogenicity Following Pressure Overload in Rats via the Modulation of Cardiac Electrical and Structural Remodeling and Calcium Handling Dysfunction.
Chang GJ; Yeh YH; Chen WJ; Ko YS; Lai YJ; Lee YS
J Am Heart Assoc; 2022 Aug; 11(15):e024285. PubMed ID: 35862154
[TBL] [Abstract][Full Text] [Related]
9. SIRT2 regulates microtubule stabilization in diabetic cardiomyopathy.
Yuan Q; Zhan L; Zhou QY; Zhang LL; Chen XM; Hu XM; Yuan XC
Eur J Pharmacol; 2015 Oct; 764():554-561. PubMed ID: 26209361
[TBL] [Abstract][Full Text] [Related]
10. Aminoguanidine prevents the impairment of cardiac pumping mechanics in rats with streptozotocin and nicotinamide-induced type 2 diabetes.
Wu MS; Liang JT; Lin YD; Wu ET; Tseng YZ; Chang KC
Br J Pharmacol; 2008 Jun; 154(4):758-64. PubMed ID: 18376420
[TBL] [Abstract][Full Text] [Related]
11. Advanced glycation end-products are responsible for the impairment of corpus cavernosal smooth muscle relaxation seen in diabetes.
Cartledge JJ; Eardley I; Morrison JF
BJU Int; 2001 Mar; 87(4):402-7. PubMed ID: 11251537
[TBL] [Abstract][Full Text] [Related]
12. ALT-946 and aminoguanidine, inhibitors of advanced glycation, improve severe nephropathy in the diabetic transgenic (mREN-2)27 rat.
Wilkinson-Berka JL; Kelly DJ; Koerner SM; Jaworski K; Davis B; Thallas V; Cooper ME
Diabetes; 2002 Nov; 51(11):3283-9. PubMed ID: 12401720
[TBL] [Abstract][Full Text] [Related]
13. Advanced glycation end products modulate electrophysiological remodeling of right ventricular outflow tract cardiomyocytes: A novel target for diabetes-related ventricular arrhythmogenesis.
Chen YC; Lu YY; Wu WS; Lin YK; Chen YA; Chen SA; Chen YJ
Physiol Rep; 2022 Nov; 10(21):e15499. PubMed ID: 36325589
[TBL] [Abstract][Full Text] [Related]
14. Aminoguanidine prevents arterial stiffening in a new rat model of type 2 diabetes.
Chang KC; Tseng CD; Wu MS; Liang JT; Tsai MS; Cho YL; Tseng YZ
Eur J Clin Invest; 2006 Aug; 36(8):528-35. PubMed ID: 16893374
[TBL] [Abstract][Full Text] [Related]
15. Advanced glycation end products (AGEs) increase renal lipid accumulation: a pathogenic factor of diabetic nephropathy (DN).
Yuan Y; Sun H; Sun Z
Lipids Health Dis; 2017 Jun; 16(1):126. PubMed ID: 28659153
[TBL] [Abstract][Full Text] [Related]
16. Functional and structural abnormalities in the nerves of type I diabetic baboons: aminoguanidine treatment does not improve nerve function.
Birrell AM; Heffernan SJ; Ansselin AD; McLennan S; Church DK; Gillin AG; Yue DK
Diabetologia; 2000 Jan; 43(1):110-6. PubMed ID: 10672451
[TBL] [Abstract][Full Text] [Related]
17. Effects of selenium on altered mechanical and electrical cardiac activities of diabetic rat.
Ayaz M; Ozdemir S; Ugur M; Vassort G; Turan B
Arch Biochem Biophys; 2004 Jun; 426(1):83-90. PubMed ID: 15130786
[TBL] [Abstract][Full Text] [Related]
18. Gene expression of receptor for advanced glycosylation end products and its modulation by aminoguanidine in diabetic kidney tissue.
Huang Y; Lin S; Zhou J
Chin Med J (Engl); 1998 Aug; 111(8):698-704. PubMed ID: 11245022
[TBL] [Abstract][Full Text] [Related]
19. Aminoguanidine prolongs survival in azotemic-induced diabetic rats.
Friedman EA; Distant DA; Fleishhacker JF; Boyd TA; Cartwright K
Am J Kidney Dis; 1997 Aug; 30(2):253-9. PubMed ID: 9261037
[TBL] [Abstract][Full Text] [Related]
20. Effect of carnosine, aminoguanidine, and aspirin drops on the prevention of cataracts in diabetic rats.
Yan H; Guo Y; Zhang J; Ding Z; Ha W; Harding JJ
Mol Vis; 2008; 14():2282-91. PubMed ID: 19081783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
